The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMYRIS INC | COM NEW | 03236M200 | 1,300 | 292,398 | SH | SOLE | 292,398 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 4,200 | 1,331,358 | SH | SOLE | 1,331,358 | 0 | 0 | ||
BIONTECH SE | SPONSORED ADS | 09075V102 | 25,400 | 148,674 | SH | SOLE | 148,674 | 0 | 0 | ||
BUTTERFLY NETWORK INC | CL A COM | 124155102 | 4,800 | 1,011,003 | SH | SOLE | 1,011,003 | 0 | 0 | ||
CUREVAC N V | COM | N2451R105 | 33,500 | 1,709,781 | SH | SOLE | 1,709,781 | 0 | 0 | ||
EXSCIENTIA | ADS | 30223G102 | 22,900 | 1,590,909 | SH | SOLE | 1,590,909 | 0 | 0 | ||
IMMUNCORE HLDGS PLC | ADS | 45258D105 | 17,200 | 576,923 | SH | SOLE | 576,923 | 0 | 0 | ||
LUMIRADX LIMITED | SHS | G5709L109 | 33,400 | 5,574,059 | SH | SOLE | 5,574,059 | 0 | 0 | ||
SERA PROGNOSTICS INC | CL A COM | 81749D107 | 3,000 | 799,814 | SH | SOLE | 799,814 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 40,100 | 1,559,142 | SH | SOLE | 1,559,142 | 0 | 0 | ||
ZYMERGEN INC | COM | 98985X100 | 200 | 59,970 | SH | SOLE | 59,970 | 0 | 0 |